Do Symptoms and Quality of Life Differ between Focal and Diffuse Coronary Artery Disease?

Changes in fractional flow reserve (FFR) values after percutaneous coronary intervention (PCI) are associated with improvement in angina symptoms. The pattern of baseline coronary artery disease influences the degree of variation in FFR after stent implantation.

La coronariografía precoz reduce la mortalidad en SCA sin supradesnivel del ST de alto riesgo

Focal coronary artery disease leads to high post-PCI FFR values, while the improvement is not as marked in diffuse coronary artery disease. Baseline pattern of coronary disease can anticipate the likelihood of successful improvement in angina symptoms. However, the definition of diffuse disease has not been standardized and is often based on visual assessment, limiting its accuracy and repeatability.

Using the pullback pressure gradient (PPG) of the FFR, the aim of this subanalysis of the randomized, prospective, single-center study TARGET-FFR (Trial of Angiography vs. pressure-Ratio-Guided Enhancement Techniques-Fractional Flow Reserve) was to investigate the differential effect on patient-reported outcomes of PCI on focal (PPG ≥0.66) and diffuse (PPG <0.66) disease.

The endpoints were questionnaires to assess the presence of angina and patient quality of life.

A total of 103 patients were analyzed: 51 had focal disease and 52 had diffuse disease. There were no differences in baseline characteristics between the two groups. The mean PPG was 0.66. Patients with focal disease were treated with fewer (p = 0.022) and shorter (p = 0.015) stents. In addition, this population had higher post-PCI FFR values (p < 0.001) and greater change was observed after intervention (p < 0.001).

Read also: Pulmonary Artery Denervation: Valid Alternative for Pulmonary Arterial Hypertension Grade 1?

After PCI, almost 40% of patients experienced residual angina, which was significantly lower in patients with focal disease compared with diffuse disease (27.5% vs. 51.9%, respectively; p = 0.020). In addition, patients with focal coronary artery disease reported less angina, less physical limitation, and better quality of life.

On the other hand, after PCI, patients with focal disease experienced increased mobility and self-care, and decreased pain and discomfort. There were no differences in the presence of anxiety and/or depression between both groups.

Conclusion

Residual angina after PCI was frequent and found in patients with diffuse coronary disease defined as pre-PCI PPG. After PCI, patients with focal disease experienced angina improvement and better quality of life. PPG was useful to identify patients who would benefit from percutaneous revascularization in terms of symptomatic improvement.

Dr. Andrés Rodríguez.
Member of the editorial board of SOLACI.org.

Original Title: Differential Improvement in Angina and Health-Related Quality of Life After Percutaneous Coronary Interventions in Focal and Diffuse Coronary Artery Disease.

Reference: Carlos Collet, MD, PHD et al J Am Coll Cardiol Intv 2022.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...